Evidence map›Paper›PMID 22595301›Full record

ArticleJournal of the American Society of Nephrology : JASN2012

Renal denervation in moderate to severe CKD.

Dagmara Hering, Felix Mahfoud, Antony S Walton, Henry Krum, Gavin W Lambert, Elisabeth A Lambert, Paul A Sobotka, Michael Böhm, Bodo Cremers, Murray D Esler and 1 more

3 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 134 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 7 pooled it
41.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01932450 phase2unknown statusnot on this mapstarted 2013, after this paper: background citation

A Randomized, Open-label Study Investigating the Effect of Bilateral Renal Artery Sympathetic Denervation by Catheter-based Radiofrequency Ablation on Blood Pressure and Disease Progression in Autosomal Dominant Polycystic Kidney Disease

TypeinterventionalSponsorMei changlinRan2013 to 2015Enrolled100ConditionsAutosomal Dominant Polycystic Kidney Disease, HypertensionArmsrenal sympathetic denervation, antihypertensive drugs
NCT04264403 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorUniversity of Erlangen-Nürnberg Medical SchoolRan2020 to 2024Enrolled44ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease stage3ArmsRenal denervation
NCT07742787 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Renal Denervation on Blood Pressure in Patients With Chronic Kidney Disease and Uncontrolled Hypertension

TypeinterventionalSponsorHippocration General HospitalRan2024 to 2027Enrolled20ConditionsUncontrolled Hypertension, Renal Denervation, Chronic Kidney Disease (Stage 3)ArmsRenal denervation, Sham procedure control
3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 7 syntheses or guidelines pooled it, 354 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Systematic review of renal denervation for the management of cardiac arrhythmias.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Pooled it
  6. Pooled it
  7. Renal artery denervation for treating resistant hypertension : definition of the disease, patient selection and description of the procedure.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2012
    Guideline
  8. Trial
  9. Pleiotropic effects of renal denervation beyond blood pressure reduction.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  10. Review
  11. Review
  12. Observational
  13. Increased plasma levels of erythropoietin after renal denervation in patients with resistant hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  14. Future perspective on chronic kidney disease management.Journal of anesthesia and translational medicine · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Effects of renal denervation on the kidney: albuminuria, proteinuria, and renal function.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Dagmara HeringNeurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia.
Felix Mahfoud
Antony S Walton
Henry Krum
Gavin W Lambert
Elisabeth A Lambert
Paul A Sobotka
Michael Böhm
Bodo Cremers
Murray D Esler
Markus P Schlaich
Baker Heart and Diabetes Institute · AUThe Alfred Hospital · AUUniversitätsklinikum des Saarlandes · DEGdańsk Medical University · PLHennepin County Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sympathetic activation contributes to the progression of CKD and is associated with adverse cardiovascular outcomes. Ablation of renal sympathetic nerves reduces sympathetic nerve activity and BP in patients with resistant hypertension and preserved renal function, but whether this approach is safe and effective in patients with an estimated GFR (eGFR) < 45 ml/min per 1.73 m(2) is unknown. We performed bilateral renal denervation in 15 patients with resistant hypertension and stage 3-4 CKD (mean eGFR, 31 ml/min per 1.73 m(2)). We used CO(2) angiography in six patients to minimize exposure to contrast agents. Estimated GFR remained unchanged after the procedure, irrespective of the use of CO(2) angiography. Mean baseline BP ± SD was 174 ± 22/91 ± 16 mmHg despite the use of 5.6 ± 1.3 antihypertensive drugs. Mean changes in office systolic and diastolic BP at 1, 3, 6, and 12 months were -34/-14, -25/-11, -32/-15, and -33/-19 mmHg, respectively. Night-time ambulatory BP significantly decreased (P<0.05), restoring a more physiologic dipping pattern. In conclusion, this study suggests a favorable short-term safety profile and beneficial BP effects of catheter-based renal nerve ablation in patients with stage 3-4 CKD and resistant hypertension.

Indexed as

Severity of Illness IndexAgedCatheter AblationChronic DiseaseComorbidityDisease ProgressionFemaleHumansHypertension, RenalKidneyKidney DiseasesMaleMiddle AgedPilot ProjectsSympathectomyTreatment Outcome

Identifiers

PMID22595301
PMCPMC3380649
OpenAlexW2099897414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.